Neuroprotectants FK-506 and cyclosporin A ameliorate the course of pilocarpine-induced seizures
| Autor: | Małgorzata Ciarach, Zuzanna Setkowicz |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Male
Agonist medicine.drug_class Status epilepticus Neuroprotection Tacrolimus Epilepsy Status Epilepticus Seizures Cyclosporin a Muscarinic acetylcholine receptor medicine Animals Rats Wistar Behavior Animal Chemistry Pilocarpine Ciclosporin medicine.disease Rats Neuroprotective Agents Neurology Anesthesia Cyclosporine Neurology (clinical) medicine.symptom medicine.drug |
| Zdroj: | Epilepsy Research. 73:151-155 |
| ISSN: | 0920-1211 |
| DOI: | 10.1016/j.eplepsyres.2006.09.001 |
| Popis: | The present study was designed to examine whether neuroprotective agents, FK506 or cyclosporin A (CsA), applied to rats undergoing pilocarpine-induced seizures can minimize further development of the status epilepticus. In order to solve this problem, pilocarpine was injected in 60-day-old Wistar rats to evoke status epilepticus. When epileptic seizures reached a defined, moderate level of intensity, the rats received a single FK506 or CsA injections. During a 6-h period following pilocarpine injection, the animals were observed continuously and motor symptoms were recorded and rated. In epileptic rats injected with FK-506 or CsA, signs of significant amelioration of the course of epilepsy accompanied by longer survival periods were observed. Moreover, some differences between effects of the two agents were seen. The obtained results appear to show that, in addition to neuroprotective action, FK506 and CsA can exert also antiepileptic influences. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect